Maha FDA seizes drug stocks in violation of Drugs & Magic Remedies Act

Mumbai
Maharashtra Food and Drug Administration (FDA) recently raided the premises of a Mumbai based firm Rajasthan Aushdhalaya Pvt Ltd and seized ayurvedic drugs worth Rs.2.04 lakhs. These ayurvedic drugs were mixed with allopathic medicines in contravention to the provisions of the Drugs and Magic Remedies (Objectionable advertisement) Act (DMR Act) 1954.DMR Act seeks to curtail undesirable advertisements pertaining to drugs and magic remedies because advertising is considered to encourage self medication of harmful drugs. The Act lists the diseases and disorders in respect of which advertising is banned under Section 3 of the Drugs and Magic Remedies Act, 1954. Products that were seized were manufactured at Rajasthan Herbal International, Ayurvedic Park, Jhunjhunu, Rajasthan and Hurni Herboceuticals, Rajasthan. The intelligence Branch of the Maharashtra FDA seized the stock of Leucwin Syrup, Leucwin Capsules, Kaya Cure Churna, Nari Amrut Syrup, Diab Hari Churna, Raj Pro Xtra Power, Mood on Forever Capsule based on a tip-off. The objectionable advertisement of the ayurvedic drugs were also being published in news papers where the drugs were shown to cure ailments like cancer, hormonal disturbances, female genital tract problems, erectile dysfunction, premature ejaculation, enhancing the breast cup size, etc.The main objective of DMR Act is to control the advertisement of drugs in certain cases and to prohibit the advertisement connected with remedies alleged to posses magic qualities and to provide for matters connected therewith. Under the DMR Act, the definition of “Magic Remedy” includes a talisman, mantra, kavacha and any other charm of any kind which is alleged to possess miraculous powers for or in the diagnosis, cure, mitigation, treatment or prevention of any disease in human beings or animals or for affecting or influencing in any way the structure or any organic function of the body of human beings or animals.